Genetic Epilepsy Family Conference 2026 – Speakers

Sara James

Sara James is an Emmy Award-winning broadcast journalist and author who has covered major news events for NBC, CNN and PBS. She is Chair of the Australian-American Fulbright Commission and Vice President of the KCNQ2 Cure Alliance. Sara is a co-founder of Genetic Epilepsy Team Australia and as a rare disease mum, Sara is a passionate advocate for collaboration, research progress and strengthening connections between families, clinicians and researchers.

Sara James

Prof Annapurna Poduri

Professor Annapurna Poduri is a leading clinician-scientist at Harvard Medical School and Boston Children’s Hospital. Specialising in the genetics of epilepsy and neurodevelopmental disorders, she will provide important updates on her work and advances in precision medicine to improve diagnosis, treatment and outcomes for individuals with rare genetic epilepsies. 

Prof Ann Poduri

Prof Ingrid Scheffer AO

A world-leading paediatric neurologist and expert in developmental and epileptic encephalopathies. Based at the University of Melbourne, Austin Health and the Royal Children’s Hospital, she has helped transform epilepsy diagnosis and precision medicine through her groundbreaking gene discoveries.

Prof Ingrid Scheffer AO

Amy Schneider

Amy Schneider is a Senior Clinical Research Scientist at the Epilepsy Research Centre, University of Melbourne. She leads the Developmental and Epileptic Encephalopathy Research (DEER) study, working with families to perform deep phenotyping and identify genetic diagnoses. Amy has a Master of Genetic Counselling and extensive experience in translational research investigating the genetic basis of epilepsy.

Amy Schneider

A/Prof Lata Vadlamudi

Associate Professor Lata Vadlamudi is an epileptologist and Senior Staff Specialist in Neurology at the Royal Brisbane and Women’s Hospital and leads the Epilepsy Research Program at the Frazer Institute, The University of Queensland. Her research interests include precision-based treatment for drug-resistant epilepsy and women with epilepsy.  She is the Vice-President of the Epilepsy Society of Australia.

A/Prof Lata Vadlamudi

Dr Yuri Maricich

Dr Yuri Maricich is Chief Medical Officer at Camp4 Therapeutics, a clinical-stage company developing RNA-targeting therapies for genetic diseases including developmental and epileptic encephalopathies. He has led development of novel therapeutics across neuroscience and rare disease, including the first FDA-cleared prescription digital therapeutics. He holds an MD from the University of Washington and an MBA from Harvard Business School.

Dr Yuri Maricich

Maddison Smith

Maddison Smith is currently a PhD student and Research Assistant in the Faculty of Medicine and Health at the University of New South Wales. She graduated with a Bachelor of Psychology with Honours in 2023 and has since worked as a Research Officer at St Vincent’s Hospital Sydney. Maddison is passionate about communicating how psychology and mental health should be embedded in clinical care across the healthcare system for both patients and families. The focus of her PhD is on how to support the psychosocial wellbeing of siblings of patients with rare epilepsy conditions. 

Maddison will introduce her research on supporting siblings of individuals with rare, genetic epilepsy conditions. This includes a new, online program called SIBS-ONLINE, and future opportunities to be involved in the development of support resources. You can find more information about SIBS-ONLINE here: https://www.unsw.edu.au/research/behavioural-sciences-unit/research/mental-health-and-relationships/sibs-online

Maddison Smith

Prof Jenny Downs

Professor Jenny Downs is head of the child disability team at The Kids Research Institute Australia in Perth. Her research includes focus on rare neurodevelopmental disorders including Rett syndrome, CDKL5 Deficiency Disorder and developmental epileptic encephalopathy conditions. She has particular expertise in developing and validating measures of motor skills, communication and quality of life for children with intellectual disability conditions.

A/Prof Jenny Downs

A/Prof Jasneek Chawla

Associate Professor Jasneek Chawla is a Consultant Physician in Paediatric Respiratory and Sleep Medicine at Queensland Children’s Hospital and is the President of the Australasian Sleep Association. Her research focuses on sleep in children with disability, the relationship between sleep and cognitive and behavioural outcomes, and sleep evaluation for high-risk children.

A/Prof Jasneek Chawla

A/Prof Honey Heussler

Associate Professor Honey Heussler is a Developmental and Behavioural Paediatrician and Medical Director of the Child Development Program at Queensland Children’s Hospital.  She holds dual qualifications in Developmental and Behavioural Paediatrics and Sleep Medicine, and specialises in sleep, behavioural phenotypes and clinics for genetic disorders. She also sits on scientific advisory boards and contributes to clinician education and research. 

Prof Honey Heussler

Ann Single

Ann Single is President of Health Technology Assessment international (HTAi) and a patient and public involvement specialist who coordinates the Patient Voice Initiative in Australia. She co-edited the first book on patient involvement in health technology assessment and has served as a consumer representative on Australia’s HTA Review Reference Committee.

Ann Single

Kris Pierce

Kris Pierce is co-founder of Genetic Epilepsy Team Australia, Strategic Advisor, Consumer and Community Engagement – Rare Diseases UNSW, founder of SCN2A Australia and director, Kris Pierce Consulting. Kris also serves as Deputy Chair of the Health Technology Assessment Consumer Consultative Committee at the Australian Government Department of Health, and sits on the Genomics Australia Advisory Council.

Kris Pierce

 

GETA:  GET A Team, GET A Target, GET A Cure